THOMAS RAINER FRIEDRICH SCIOR,JOSÉ ANTONIO GUEVARA GARCÍA,FRANCISCO JAVIER MELÉNDEZ BUSTAMANTE,NORMA ANGÉLICA CABALLERO CONCHA,MARÍA EUGENIA CASTRO SÁNCHEZ
申请号：
MX2015009557
公开号：
MX2015009557A
申请日:
2015.07.23
申请国别(地区):
MX
年份:
2017
代理人:
摘要：
The present disclosure is related to new vanadium derivatives, which are useful for the treatment of diabetes. Said compounds are [VVO2(OH)(2-Carboxy-pyrimidine)], [VVO2(OH)(6-methylpyridine-2-amide)], VVO2(OH)(3-Chloro-5-(Trifluoromethyl)Pyridine-2-amide)], [VVO2(OH)(diethyl2,4-pyridinediamide)], and [VVO2(OH)(N,N-Dimethyl-L-proline)] to prepare a pharmaceutical composition useful for the diabetes treatment.La presente invención proporciona nuevos derivados de vanadio , los cuales son útiles para el tratamiento de diabetes. Dichos compuestos son [VVO2(OH)(2-Carboxi-Pirimidina)], [VVO2(OH)(6-Metillpiridina-2-amida)], [VVO2(OH)(4-(Trifluorometil) piridina-2-amida)], [VVO2(OH)(6-Hidroxipicolinamida)], [VVO2(OH)(3-Cloro-5-(Trifluorometil)Piridina-2-amida)], [VVO2(OH)(dietil 2,4-piridindiamida)], y [VVO2(OH)(N,N-Dimetil-L-p rolina)] para preparar una composición farmacéutica útil para el tratamiento de diabetes.
